Committee, Organizational and Volunteer Service

National/International:

  1. Panel member, National Comprehensive Cancer Network (NCCN) Clinical Practice Guideline Panel for Testicular Cancer, 10/2008-10/2016
  2. Panel member, National Comprehensive Cancer Network (NCCN) Clinical Practice Guideline Panel for Kidney Cancer, 10/2008-present
  3. Member, Southwest Oncology Group (SWOG) – Committee for Genitourinary Cancers. 01/2009-present.
  4. Panel member, National Comprehensive Cancer Network (NCCN) Clinical Practice Guideline Panel for Bladder Cancer, 03/2010-present
  5. Leader of early therapeutics, Scientific Leadership Committee, South West Oncology Group (SWOG) – Committee for Genitourinary Cancers. 04/2010-04/2023
  6. Member, Conquer Cancer Foundation of ASCO- Grants Selection Committee, 06/2016-present
  7. Member, American Society of Clinical Oncology (ASCO) Practice Guidelines Implementation Network (PGIN). 04/2017-2019
  8. Subject Matter Expert, ASCO Advantage Program on Prostate Cancer, 06/2017
  9. Consultant, Oncology Drug Advisory Committee (ODAC), United States of America (USA) Food and Drug Administration (FDA), as a Special Government Employee (SGE). 08/20/2017-07/31/2025
  10. Faculty, ASCO University, 2018
  11. Faculty, SWOG Genitourinary committee new investigator workshop, 2019 SWOG spring meeting, San Francisco, CA. 04/2019
  12. Faculty, 2019 ASCO grant writing workshop, 2019 ASCO Annual Meeting, Chicago, IL. 5/2019
  13. Subject Matter Expert, ASCO Advantage Program on Kidney Cancer, 08/2019 and, 12/2019
  14. Member, 2019 ASCO Quality Care Symposium News Planning Team, 09/2019
  15. Member, ASCO Communications Committee, 01/2019-12/2021
  16. Member, ASCO Genitourinary Cancer Guideline Advisory Group (GAG) to the Clinical Practice Guidelines Committee, 06/2020-06/2024
  17. Moderator, U.S. Food and Drug Administration (FDA) Workshop: Clinical Trial Design for Non-Muscle Invasive Bladder Cancer (NMIBC), 11/2021
  18. Member, 2025 European Society of Medical Oncology (ESMO) Scientific Committee
  19. Steering Committee and Panel Member, 2023-2025 United States (US) Prostate Cancer Conference
  20. Panel Member, Advanced Prostate Cancer Conference (APCCC), Lugano, Switzerland
  21. Member, Vogelzang Scholar Selection Committee, SWOG, 11/2024-present
  22. Member, ASCO Ed Book Editor-in-Chief Search Committee, 03/2025-present
  23. Member, Patient Information Advisory Committee, ASCO, 2025-2028

Institutional:

  1. Member, Protocol Review and Monitoring Committee (PRMC), Huntsman Cancer Institute, University of Utah, 01/2010-Present
  2. Member, University of Utah School of Medicine Tenured and Clinical Faculty Review Committee, Department of Internal Medicine. 2009-2018
  3. Member, University of Utah School of Medicine, Admissions Committee. 08/2012-06/2014
  4. Member, Physician Scientist Recruitment Committee, Huntsman Cancer Institute,   University of Utah. 2014- Present
  5. Member, Fellowship Research Curriculum Committee, University of Utah Hematology Oncology Fellowship Program. 2014-Present
  6. Director, Center of Investigational Therapeutics (CIT), Huntsman Cancer Institute,   University of Utah. 2017- Present
  7. Member, Research Trials Review Committee (RTRC), Huntsman Cancer Institute, University of Utah. 05/2021-Present
  8. Member and School of Medicine Representative, Conflict of Interest (COI) Committee, University of Utah, 10/2021-08/2025

Others:

  1. Invited Panelist, MD Anderson Cancer Center sponsored “9th Annual Oncology Update: Advances and Controversies”, Park City, Utah. 01/18/2008
  2. Invited Panelist, MD Anderson Cancer Center sponsored “8th Annual Oncology Update: Advances and Controversies”, Park City, Utah. 01/20/2008
  3. Member, MSCI Committee. Nick Frazier – M.S. Clinical Investigation candidate, Department of Bioengineering, USTAR-Ghandehari Group, University of Utah, Salt Lake City, Utah. 07/2014-06/2016
  4. PhD Thesis Reviewer, Nazia Syed – Biochemistry and Molecular Biology. Pondicherry University, Pudhucherry, India. 06/2016
  5. Member, Society of Utah Medical Oncologists (SUMO) Board, 2/2024-present
Follow me on Twitter